Synthesis and biochemical characterisation of fluorinated analogues of pepstatin A and grassystatin A

[1]  V. Paul,et al.  Tasiamide F, a potent inhibitor of cathepsins D and E from a marine cyanobacterium. , 2016, Bioorganic & medicinal chemistry.

[2]  L. Hunter,et al.  Diastereoselective Synthesis and Conformational Analysis of (2R)- and (2S)-Fluorostatines: An Approach Based on Organocatalytic Fluorination of a Chiral Aldehyde. , 2016, Organic letters.

[3]  Arun K. Ghosh,et al.  Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. , 2016, Journal of medicinal chemistry.

[4]  Neil J Wells,et al.  Investigating the Influence of (Deoxy)fluorination on the Lipophilicity of Non‐UV‐Active Fluorinated Alkanols and Carbohydrates by a New log P Determination Method , 2015, Angewandte Chemie.

[5]  M. D. Hill,et al.  Applications of Fluorine in Medicinal Chemistry. , 2015, Journal of medicinal chemistry.

[6]  Matthew P Jacobson,et al.  Probing the Physicochemical Boundaries of Cell Permeability and Oral Bioavailability in Lipophilic Macrocycles Inspired by Natural Products. , 2015, Journal of medicinal chemistry.

[7]  A. Hallberg,et al.  Aspartic protease inhibitors containing tertiary alcohol transition-state mimics. , 2015, European journal of medicinal chemistry.

[8]  J. Essex,et al.  A computational study of vicinal fluorination in 2,3-difluorobutane: implications for conformational control in alkane chains. , 2015, Chemistry.

[9]  Jie Lu,et al.  CPY3A4-Mediated α-Hydroxyaldehyde Formation in Saquinavir Metabolism , 2014, Drug Metabolism and Disposition.

[10]  G. Wolber,et al.  Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans. , 2013, Biochemical pharmacology.

[11]  L. Hunter,et al.  Solid phase synthesis of peptides containing backbone-fluorinated amino acids. , 2012, Organic & biomolecular chemistry.

[12]  Wei Zhang,et al.  Total synthesis of grassystatin A, a probe for cathepsin E function. , 2012, Bioorganic & medicinal chemistry.

[13]  J. Graton,et al.  An Unexpected and Significantly Lower Hydrogen-Bond-Donating Capacity of Fluorohydrins Compared to Nonfluorinated Alcohols** , 2012, Angewandte Chemie.

[14]  S. Miertus,et al.  Insight into Selectivity of Peptidomimetic Inhibitors with Modified Statine Core for Plasmepsin II of Plasmodium falciparum over Human Cathepsin D , 2012, Chemical Biology and Drug Design.

[15]  B. Jaun,et al.  Note: Helix or No Helix of β‐Peptides Containing β3hAla(αF) Residues? , 2011 .

[16]  L. Hunter,et al.  The C–F bond as a conformational tool in organic and biological chemistry , 2010, Beilstein journal of organic chemistry.

[17]  Hendrik Luesch,et al.  Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. , 2009, Journal of medicinal chemistry.

[18]  B. Koksch,et al.  Investigation of the synthetic route to pepstatin analogues by SPPS using O‐protected and O‐unprotected statine as building blocks , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[19]  S. Purser,et al.  Fluorine in medicinal chemistry. , 2008, Chemical Society reviews.

[20]  B. Jaun,et al.  NMR‐Solution Structures of Fluoro‐Substituted β‐Peptides: A 314‐Helix and a Hairpin Turn. The First Case of a 90° OCCF Dihedral Angle in an α‐Fluoro‐Amide Group , 2007 .

[21]  B. Dunn,et al.  Aspartic Peptidase Inhibitors: Implications in Drug Development , 2003, Critical reviews in biochemistry and molecular biology.

[22]  B. Zhong,et al.  Asymmetric synthesis of chiral organofluorine compounds: use of nonracemic fluoroiodoacetic acid as a practical electrophile and its application to the synthesis of monofluoro hydroxyethylene dipeptide isosteres within a novel series of HIV protease inhibitors. , 2001, Journal of the American Chemical Society.

[23]  R. Obach,et al.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[24]  J. Plavec,et al.  A New Generalized Karplus-Type Equation Relating Vicinal Proton-Fluorine Coupling Constants to H−C−C−F Torsion Angles , 1998 .

[25]  W. Kati,et al.  Difluorostatine- and difluorostatone-containing peptides as potent and specific renin inhibitors. , 1985, Journal of medicinal chemistry.

[26]  M. Gelb,et al.  Fluoro ketone inhibitors of hydrolytic enzymes. , 1985, Biochemistry.

[27]  S. C. Smith,et al.  Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers. , 1979, Journal of medicinal chemistry.

[28]  A. Barrett,et al.  Interaction of human cathepsin D with the inhibitor pepstatin. , 1976, The Biochemical journal.

[29]  T. Aoyagi,et al.  The structure of pepstatin. , 1970, The Journal of antibiotics.